Hyperprolactinemia: neuroendocrine and diagnostic aspects (Q38724656)

5 September 2017

1 reference

title

Hyperprolactinemia: neuroendocrine and diagnostic aspects (English)

1 reference

5 September 2017

Camanni F

1

1 reference

5 September 2017

Ciccarelli E

series ordinal

2

1 reference

5 September 2017

Ghigo E

series ordinal

3

1 reference

5 September 2017

Müller EE

series ordinal

4

1 reference

5 September 2017

publication date

1 October 1989

1 reference

Journal of Endocrinological Investigation

5 September 2017

published in

1 reference

5 September 2017

volume

12

1 reference

5 September 2017

issue

9

1 reference

5 September 2017

page(s)

653-668

1 reference

Electrophoretic evidence for human prolactin

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

A radioimmunoassay for human prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Hypothalamic-pituitary function in diverse hyperprolactinemic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

A defect in catecholamine neurons in patients with prolactin-secreting pituitary adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

The effects of the gabaergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

The food-entrained prolactin and cortisol release in late pregnancy and prolactinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

A Sequential Pituitary Stimulation Test in Normal Subjects and in Patients with Amenorrhea-Galactorrhea with Pituitary Tumors*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Hyperprolactinemic anovulatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Opiate mediation of amenorrhoea in hyperprolactinaemia and in weight-loss related amenorrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Dopamine-mimetic and antagonist drugs: diagnostic and therapeutic applications in endocrine disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Comparison of the Responses in the Nomifensine Test with Hyperprolactinemia due to Prolactin-Secreting Pituitary Tumors and Nonprolactin-Secreting Hypothalamic Tumors*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Defective central nervous system dopaminergic function in rats with estrogen-induced pituitary tumors, as assessed by plasma prolactin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Decline of tuberoinfundibular dopaminergic function resulting from chronic hyperprolactinemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Differential effects of a low dose dopamine infusion on prolactin secretion in normal and hyperprolactinemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Evidence for lactotroph dopamine resistance in idiopathic hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Prolactin-secreting adenomas in women. VII. Dopamine regulation of prolactin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Dopamine infusion studies in patients with pathological hyperprolactinemia: evidence of normal prolactin suppressibility but abnormal dopamine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Tests of prolactin secretion in diagnosis of prolactinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Hypothalamic secretion of dopamine after inhibition of aromatic L-amino acid decarboxylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Failure of dopamine infusion to suppress the plasma prolactin response to sulpiride in normal and hyperprolactinemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Functional characterization of hypothalamic hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Prolactin turnover in rat adenohypophyses in vivo: its evaluation as a method for estimating secretion rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Hypothalamic-pituitary function in patients with craniopharyngiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Sustained Elevation of Serum Prolactin by Metoclopramide: A Clinical Model of Idiopathic Hyperprolactinemia*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Evidence for dopaminergic control of thyrotrophin secretion in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Defective regulation of prolactin secretion after successful removal of prolactinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Abnormal regulation of prolactin secretion after successful surgery for prolactin-secreting pituitary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Prolactin Secreting Tumors Endocrine Status before and after Surgery in 33 Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Gradual recovery of lactotroph responsiveness to dynamic stimulation following surgical removal of prolactinomas: long-term follow-up studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Microvasculature of human micro- and macroprolactinomas. A morphological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Estrogenic treatment does not modify the TSH and PRL responses to domperidone and TRH in patients with tumoral hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Prolactin-secreting pituitary tumors in amenorrheic women: a comprehensive study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

The specificity of serum prolactin as a diagnostic indicator of pituitary adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Pituitary adenomas associated with hyperprolactinemia: a clinical and immunohistochemical study of 97 patients operated on transsphenoidally

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350030

Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients

21 January 2018

1 reference

12 December 2020

Basal and TRH stimulated serum levels of TSH in patients with hyperprolactinaemia and in subjects on oestrogen treatment

1 reference

12 December 2020

Influence of prolactin on dopaminergic neuronal systems in the hypothalamus

1 reference

12 December 2020

Galactorrhea, oligo/amenorrhea, and hyperprolactinemia in patients with craniopharyngiomas

1 reference

12 December 2020

Enhanced hypothalamic dopaminergic inhibition of LH, TSH and GH release in patients with pathological hyperprolactinaemia.

1 reference

12 December 2020

Prolactin response to dopamine synthesis inhibition using monoiodotyrosine in subjects on oral contraceptives and patients with pathological hyperprolactinemia

1 reference

12 December 2020

Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia

1 reference

12 December 2020

Biochemical indices of tuberoinfundibular dopaminergic neuronal activity during lactation: a lack of response to prolactin

1 reference

12 December 2020

Prolactin lowering effect of amphetamine in normoprolactinemic subjects and in physiological and pathological hyperprolactinemia

1 reference

12 December 2020

Benserazide, a stimulator of prolactin release: a new test in the diagnosis of pituitary prolactin-secreting tumours

1 reference

12 December 2020

Pituitary tumors and hyperprolactinemia

1 reference

12 December 2020

3HSpiperone Binding to Human Anterior Pituitaries and Pituitary Adenomas Secreting Prolactin, Growth Hormone, and Adrenocorticotropic Hormone*

1 reference

12 December 2020

Pituitary Function Following Surgery for Prolactinomas

1 reference

12 December 2020

Studies on prolactin in man

1 reference

12 December 2020

1 reference

12 December 2020

Central nervous system-mediated stimulation of prolactin secretion by cimetidine, a histamine H2-receptor antagonist: impaired responsiveness in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia

1 reference

12 December 2020

Prolactin and growth hormone responses in the amenorrhea-galactorrhea syndrome

1 reference

12 December 2020

Diurnal variation of prolactin secretion differentiates pituitary tumors from the primary empty sella syndrome

1 reference

12 December 2020

Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone

1 reference

12 December 2020

A new pharmacological approach to the diagnosis of hyperprolactinaemic states: the nomifensine test

1 reference

12 December 2020

Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas. Stimulation of PRL release and activation of adenylate cyclase

1 reference

12 December 2020

Increased thyrotrophin secretion induced by sulpiride in man

1 reference

12 December 2020

Evidence for increased dopaminergic inhibition of secretion of thyroid-stimulating hormone in hyperprolactinemic patients with pituitary microadenoma

1 reference

12 December 2020

Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade

1 reference

12 December 2020

Galactorrhea, amenorrhea, and hyperprolactinemia as manifestations of parasellar meningioma

1 reference

12 December 2020

[VIP removes the inhibition of prolactin secretion induced by dopamine in patients with prolactinoma]

1 reference

12 December 2020

Dopaminergic receptors in human prolactin-secreting adenomas: a quantitative study

1 reference

12 December 2020

Catecholamines and pituitary function. IV. Effects of low-dose dopamine infusion and long-term bromocriptine treatment on the abnormal thyrotroph (TSH) dynamics in patients with pathological hyperprolactinaemia

1 reference

12 December 2020

Effects of a dopamine antagonist (metoclopramide) on the release of the adenohypophyseal hormones in amenorrhoeic patients with and without hyperprolactinaemia

1 reference

12 December 2020

Pituitary computed tomography and dynamic tests of prolactin and thyrotropin secretion in 103 hyperprolactinemic patients

1 reference

12 December 2020

Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma

1 reference

12 December 2020

Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.

1 reference

12 December 2020

Release of Newly Synthesized Dopamine into the Hypophysial Portal Vasculature of the Rat*

1 reference

12 December 2020

Lack of plasma prolactin response to intravenously injected vasoactive intestinal polypeptide in patients with prolactin-secreting adenoma

1 reference

12 December 2020

Serum prolactin in patients with hypothalamus and pituitary disorders

1 reference

12 December 2020

Dopamine in plasma of lateral and medial hypophysial portal vessels: evidence for regional variation in the release of hypothalamic dopamine into hypophysial portal blood

1 reference

12 December 2020

Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery

1 reference

12 December 2020

Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors

1 reference

12 December 2020

Evidence of Receptors for Thyrotropin-Releasing Hormone in Human Prolactin- Secreting Adenomas*

1 reference

12 December 2020

Diagnosis and management of prolactinomas

1 reference

12 December 2020

Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas

1 reference

12 December 2020

TSH response to domperidone

1 reference

12 December 2020

Subclinical Adenoma of the Pituitary Gland.

1 reference

12 December 2020

Effect of sulpiride on plasma prolactin levels in women with puerperal or pathological hyperprolactinaemia

1 reference

12 December 2020

Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia

1 reference

12 December 2020

Prolactin-releasing effect of domperidone in normoprolactinemic and hyperprolactinemic subjects

1 reference

12 December 2020

Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome

1 reference

12 December 2020

Dynamic testing of prolactin and growth hormone secretion in patients with neuroendocrine disorders.

1 reference

12 December 2020

Diagnosis of pituitary tumors

1 reference

12 December 2020

Agreement of prolactin response to cimetidine and nomifensine in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia

1 reference

12 December 2020

Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea an the response to bromocriptine therapy

1 reference

12 December 2020

Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series

1 reference

12 December 2020

An inhibitory role for morphine on the release of dopamine into hypophysial portal blood and on the synthesis of dopamine in tuberoinfundibular neurons

1 reference

12 December 2020

Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology

1 reference

12 December 2020

Effect of two indirectly acting dopamine agonists on prolactin secretion in normo- and hyperprolactinemic subjects: comparison with the effect of nomifensine

1 reference

12 December 2020

Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas

1 reference

12 December 2020

Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women

1 reference

12 December 2020

Hormonal and Metabolic Abnormalities Associated with Central Nervous System Germinoma in Children and Adolescents and the Effect of Therapy: Report of 10 Patients*

1 reference

12 December 2020

Patterns of spontaneous LH release in normo- and hyperprolactinaemic women

1 reference

12 December 2020

The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors.

1 reference

12 December 2020

Prolactin and TSH response to alpha-methyl-l-tyrosine in normal subjects and in women with pathological hyperprolactinemia

1 reference

12 December 2020

Plasma pituitary hormone responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03350030

1 reference

Dimensions Publication ID

5 September 2017

1012996077

0 references

1 reference